Utah Medical Products, Inc. (UTMD)

Market Cap	231.69M +18.3%
Revenue (ttm)	36.11M -7.0%
Net Income	10.49M -16.5%
EPS	3.28 -12.4%
Shares Out	3.18M
PE Ratio	22.17
Forward PE	n/a
Dividend	$1.24 (1.70%)
Ex-Dividend Date	Sep 17, 2026

Volume	32,323
Open	72.04
Previous Close	71.80
Day's Range	71.62 - 73.34
52-Week Range	53.66 - 75.75
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 23, 2026

About UTMD

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK fee...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 152
• Stock Exchange: NASDAQ
• Ticker Symbol: UTMD
• Website: https://www.utahmed.com

Financial Performance

In 2025, Utah Medical Products's revenue was $38.52 million, a decrease of -5.83% compared to the previous year's $40.90 million. Earnings were $11.29 million, a decrease of -18.65%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 29, 2026

Data Sources Report a data error